The Role of Genomics in Enabling Prospective Health Care

Genomic and Personalized Medicine, Two-Vol Set

Volumn , Issue , 2009, Pages 378-385

  Snyderman, Ralph ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70449516092     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-369420-1.00032-9     Document Type: Chapter

References (32)

1. Anderson K.M., Wilson P.W., Odell P.M., Kannel W.B. An updated coronary risk profile. A statement for health professionals. Circulation 1991, 83:356-362.
2. Anderson K.S., LaBaer J. The sentinel within: Exploiting the immune system for cancer biomarkers. J Proteome Res 2005, 4:1123-1133.
3. Barker J.M., Barriga K.J., Yu L., Miao D., Erlich H.A., Norris J.M., Eisenbarth G.S., Rewers M. Diabetes Autoimmunity Study in the Young. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 2004, 8:3896-3902.
4. Berchuck A., Iversen E.S., Lancaster J.M., Pittman J., Luo J., Lee P., Murphy S., Dressman H.K., Febbo P.G., West M., et al. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin Cancer Res 2005, 11:3686-3696.
5. Bild A.H., Yao G., Chang J.T., Wang Q., Potti A., Chasse D., Joshi M.B., Harpole D., Lancaster J.M., Berchuck A., et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006, 439(7074):274-275.
6. Brindle P., Emberson J., Lampe F., Walker M., Whincup P., Fahey T., et al. Predictive accuracy of the Framingham coronary risk score in British men: Prospective cohort study. BMJ 2003, 327:1267-1270.
7. Bynum W. The evolution of germs and the evolution of disease: Some British debates, 1870-1900. Hist Philos Life Sci 2002, 24(1):53-68.
8. Deng M.C., Eisen H.J., Mehra M.R., Billingham M., Marboe C.C., Berry G., Kobashigawa J., Johnson F.L., Starling R.C., Murali S., et al. Non-invasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006, 6:150-160.
9. Eisenbarth G.S. Prediction of type 1 diabetes: The natural history of the prediabetic period. Adv Exp Med Biol 2004, 552:268-290.
10. Euhus D.M. Understanding mathematical models for breast cancer risk assessment and counseling. Breast J 2001, 7(4):224-232.
11. Evans D.M., Cardon L.R., Morris A.P. Genotype prediction using a dense map of SNPs. Genet Epidemiol 2004, 4:375-384.
12. Gail M., Brinton L., Byar D., Corle D., Green S., Schairer C., Mulvihill J. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81:1879-1886.
13. Garber J.E., Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol 2005, 23:276-292.
14. Langheier J.M., Snyderman R. Prospective Medicine: The role for genomics in personalized health planning. Pharmacogenomics 2004, 5(1):1-8.
15. Lee W., Lockhart A.C., Kim R.B., Rothenberg M.L. Cancer pharmacogenomics: Powerful tools in cancer chemotherapy and drug development. Oncologist 2005, 2:104-111.
16. Liu T., Johnson J.A., Casella G., Wu R. Sequencing complex diseases with HapMap. Genetics 2004, 168:503-511.
17. Listgarten J., Damaraju S., Poulin B., Cook L., Dufour J., Driga A., Mackey J., Wishart D., Greiner R., Zanke B. Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms. Clin Cancer Res 2004, 10:2725-2737.
18. Nagy R., Sweet K., Eng C. Highly penetrant hereditary cancer syndromes. Oncogene 2004, 23:6445-6470.
19. Nelson H.D., Huffman L.H., Fu R., Harris E.L. U.S. Preventive Services Task Force: Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2005, 143:362-379.
20. Niu T. Algorithms for inferring haplotypes. Genet Epidemiol 2004, 27:334-347.
21. Paik S., Shak S., Tang G., Kim C., Baker J., Cronin M., Baehner F.L., Walker M.G., Watson D., Park T., et al. A multigene assay to predict recurrence of tamoxifen-treated, node-Negative breast cancer. N Engl J Med 2004, 351:2817-2826.
22. Pittman J., Huang E., Dressman H., Horng C.F., Cheng S.H., Tsou M.H., Chen C.M., Bild A., Iversen E.S., Huang A.T., et al. Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. Proc Natl Acad Sci USA 2004, 101:8431-8436.
23. Rich J.N., Hans C., Jones B., Iversen E.S., McLendon R.E., Rasheed B.K., Dobra A., Dressman H.K., Bigner D.D., Nevins J.R., et al. Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res 2005, 65:4051-4058.
24. Santen R., Boyd N., Chlebowski R., Cummings S., Cuzick J., Dowsett M., Easton D., Forbes J., Key T., Hankinson S., et al. Critical assessment of new risk factors for breast cancer: Considerations for development of an improved risk prediction model. Endocr Relat Cancer 2007, 14(2):169-187.
25. Snyderman R. AAP Presidential address: The AAP and the transformation of medicine. J. Clin Invest 2004, 114:1169-1173.
26. Snyderman R., Langheier J. Prospective health care: The second transformation of medicine. Genome Biol 2006, 7:104-127.
27. Snyderman R., Williams R.S. Prospective medicine: The next health care transformation. Acad Med 2003, 78(11):1079-1084.
28. Snyderman R., Yoediono Z. Prospective care: A personalized, preventative approach to medicine. Pharmocogenomics 2006, 7(1):5-9.
29. The International HapMap Project. Nature 2003, 426:789-796. The International HapMap Consortium.
30. Wang Y., Klijn J.G., Zhang Y., Sieuwerts A.M., Look M.P., Yang F., Talantov D., Timmermans M., Meijer-van Gelder M.E., Yu J., et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005, 365:671-679.
31. West M., Ginsburg G., Huang A., Nevins J. Embracing the complexity of genomic data for personalized medicine. Genome Res 2006, 16:559-566.
32. Williams R.S., Willard H.F., Snyderman R. Personalized health planning. Science 2003, 300:549.